key: cord-0837901-gnt0arw1 authors: Rouai, Meriem; Slimane, Malek Ben; Sassi, Wiem; Alaoui, Fatima; Chelly, Ines; Mokni, Mourad title: Pustular rash triggered by Pfizer‐BioNTech COVID‐19 vaccination: A case report date: 2022-04-01 journal: Dermatol Ther DOI: 10.1111/dth.15465 sha: 43359e4b8b0930c7f48c79482a2e6d1f1f493c94 doc_id: 837901 cord_uid: gnt0arw1 nan receptor antagonist gene mutation supports the theory that the two diseases might share a common pathomechanism. 8, 9 Further studies with a large number of samples are needed to determine if these two diseases reflect the continuous spectrum of the same disorder. To F I G U R E 1 A plaque whose active borders are studded with nonfollicular pinhead-sized pustules and desquamation, affecting the trunk COVID-19 vaccine-induced acute generalized exanthematous pustulosis A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: case report National survey of psoriasis flares after 2009 monovalent H1N1/seasonal vaccines Generalized exacerbation of psoriasis vulgaris induced by pneumococcal polysaccharide vaccine Psoriasis flare after influenza vaccination in Covid-19 era: a report of four cases from a single center Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells Th17 cytokines and vaccine-induced immunity Acute generalized exanthematous pustulosis caused by dihydrocodeine phosphate in a patient with psoriasis vulgaris and a heterozygous IL36RN mutation Immunohistochemical comparison of IL-36 and the IL-23/Th17 axis of generalized pustular psoriasis and acute generalized exanthematous pustulosis